Hepatic lipase activity is increased in non-alcoholic fatty liver disease beyond insulin resistance-Reference-Cited by-同舟云学术

Hepatic lipase activity is increased in non-alcoholic fatty liver disease beyond insulin resistance

Published:2012-09 Issue:6 Volume:28 Page:535-541
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab Res Rev

Author:

Miksztowicz V.¹,Lucero D.¹,Zago V.¹,Cacciagiú L.¹,Lopez G.¹,Gonzalez Ballerga E.²,Sordá J.²,Fassio E.³,Schreier L.¹,Berg G.¹

Affiliation:

1. Laboratory of Lipids and Lipoproteins, Department of Clinical Biochemistry, Faculty of Pharmacy and Biochemistry, INFIBIOC; University of Buenos Aires; Buenos Aires; Argentina

2. Gastroenterology Division; University Hospital of Buenos Aires, University of Buenos Aires; Buenos Aires; Argentina

3. Hepatology Service; Muñiz Hospital; Buenos Aires; Argentina

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/dmrr.2312/fullpdf

Reference36 articles.

1. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease;Zambon;Arterioscler Thromb,1993

2. Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women;Carr;Arterioscler Thromb Vasc Biol,2002

3. Hepatic lipase: structure/function relationship, synthesis, and regulation;Perret;J Lipid Res,2002

4. Higher values of hepatic lipase activity in postmenopause: relationship with atherogenic intermediate density and low density lipoproteins;Berg;Menopause,2001

5. Lipoprotein alterations, hepatic lipase activity, and insulin sensitivity in subclinical hypothyroidism: response to L-T(4) treatment;Brenta;Thyroid,2007

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated small dense low‐density lipoprotein cholesterol to high‐density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction associated fatty liver disease in Chinese patients with type 2 diabetes mellitus;Journal of Diabetes Investigation;2024-01-22

2. Phenotypic and metabolomic characteristics of mouse models of metabolic associated steatohepatitis;Biomarker Research;2024-01-09

3. Emerging Drug Therapies for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Glimpse into the Horizon;Current Hepatology Reports;2024-01-06

4. Specific Increase in Small Dense Low-Density Lipoprotein-Cholesterol Levels beyond Triglycerides in Patients with Diabetes: Implications for Cardiovascular Risk of MAFLD;Journal of Atherosclerosis and Thrombosis;2024-01-01

5. Phenotypic and Metabolomic Characteristics of Mouse Models of Diet-Induced Hepatic Steatosis;2023-10-06